Evidence map›Paper›PMID 26626180›Full record

ArticleStem cell reports2015

Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes.

Kate Cameron, Rosanne Tan, Wolfgang Schmidt-Heck, Gisela Campos, Marcus J Lyall, Yu Wang, Baltasar Lucendo-Villarin, Dagmara Szkolnicka, Nicola Bates, Susan J Kimber and 4 more

Abstract read
In one paragraph

Article in Stem cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Article
  2. Article
  3. iScience · 2026
    Article
  4. Gene therapy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kate CameronMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK.
Rosanne TanMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK.
Wolfgang Schmidt-HeckLeibniz Institute for Natural Product Research and Infection Biology eV-Hans-Knöll Institute, 07743 Jena, Germany.
Gisela CamposIfADo-Leibniz Research Centre for Working Environment and Human Factors at the Technical University Dortmund, Ardeystraße 67, 44139 Dortmund, Germany.
Marcus J LyallMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK.
Yu WangMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK.
Baltasar Lucendo-VillarinMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK.
Dagmara SzkolnickaMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK.
Nicola BatesFaculty of Life Sciences, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK.
Susan J KimberFaculty of Life Sciences, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK.
Jan G HengstlerIfADo-Leibniz Research Centre for Working Environment and Human Factors at the Technical University Dortmund, Ardeystraße 67, 44139 Dortmund, Germany.
Patricio GodoyIfADo-Leibniz Research Centre for Working Environment and Human Factors at the Technical University Dortmund, Ardeystraße 67, 44139 Dortmund, Germany.
Stuart J ForbesMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK.
David C HayMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, UK. Electronic address: davehay@talktalk.net.

Funding

Medical Research Council G0801057Medical Research Council MR/K017047/1Medical Research Council MR/K026666/1Medical Research Council MR/L022974/1
6 · The paper itself

Abstract

Stem cell-derived somatic cells represent an unlimited resource for basic and translational science. Although promising, there are significant hurdles that must be overcome. Our focus is on the generation of the major cell type of the human liver, the hepatocyte. Current protocols produce variable populations of hepatocytes that are the product of using undefined components in the differentiation process. This serves as a significant barrier to scale-up and application. To tackle this issue, we designed a defined differentiation process using recombinant laminin substrates to provide instruction. We demonstrate efficient hepatocyte specification, cell organization, and significant improvements in cell function and phenotype. This is driven in part by the suppression of unfavorable gene regulatory networks that control cell proliferation and migration, pluripotent stem cell self-renewal, and fibroblast and colon specification. We believe that this represents a significant advance, moving stem cell-based hepatocytes closer toward biomedical application.

Indexed as

Cell Culture TechniquesCell DifferentiationCell LineCell ProliferationEmbryonic Stem CellsGene Regulatory NetworksGenome, HumanHepatocytesHumansLamininRecombinant ProteinsLamininRecombinant Proteins

Identifiers

PMID26626180
PMCPMC4682209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.